Retatrutide is not licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) and should only be used under specialist supervision or within a formal clinical trial
The Medicare GLP-1 Bridge, launching July 1, 2026 through December 31, 2027, gives eligible Aetna Medicare Advantage members weight-loss access to Wegovy at $50/month outside the Part D benefit
Alternatives include: Gentle, joyful movement (walking, dancing, yoga, etc.) Nourishing your body with enough food and a variety of nutrients Addressing sleep, stress, and mental health with size-inclusive professionals Challenging internalised weight stigma that makes us feel broken in the first place Final Thoughts Youre not wrong for being curious about these medications
Always consult with a qualified healthcare provider before starting any new therapy, including peptide treatments.
the former has been shown to help reduce body weight by 15 percent and the latter, by around 10 percent